DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.7300
-0.0200 (-2.67%)
Apr 21, 2025, 4:00 PM EDT - Market closed
DarioHealth Revenue
In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth. DarioHealth had revenue of $7.60M in the quarter ending December 31, 2024, with 110.29% growth.
Revenue (ttm)
$27.04M
Revenue Growth
+32.86%
P/S Ratio
1.36
Revenue / Employee
$133,861
Employees
202
Market Cap
30.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
| Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
| Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
| Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
| Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
DRIO News
- 8 hours ago - DarioHealth Announces CFO Transition - PRNewsWire
- 4 days ago - DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers - PRNewsWire
- 13 days ago - Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion - PRNewsWire
- 5 weeks ago - /C O R R E C T I O N -- DarioHealth Corp./ - PRNewsWire
- 6 weeks ago - DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results - PRNewsWire
- 6 weeks ago - Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula - PRNewsWire
- 6 weeks ago - Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth - PRNewsWire